EUVIMEDEUVIMED entdecken
Crossref

CPT1A Protects Podocytes From Lipotoxicity and Apoptosis In Vitro and Alleviates Diabetic Nephropathy In Vivo

Yajuan Xie, Qian Yuan, Ben Tang, Yaru Xie, Yiling Cao, Yang Qiu, Jieyu Zeng, Zhiwen Wang, Hua Su iD, Chun Zhang iD

Diabetes · 2024

DOI: 10.2337/db23-0811 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2024. Verfasst von Yajuan Xie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Apoptosis, Carnitine O-Palmitoyltransferase, Diabetes Mellitus, Experimental, Diabetic Nephropathies. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Hubei Province, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Defective fatty acid oxidation (FAO) has been implicated in diabetic kidney disease (DKD), yet little is known about the role of carnitine palmitoyltransferase-1A (CPT1A), a pivotal rate-limiting enzyme of FAO, in the progression of DKD. Here, we investigate whether CPT1A is a reliable therapeutic target for DKD. We first confirmed the downregulation expression of CPT1A in glomeruli from patients with diabetes. We further evaluated the function of CPT1A in diabetic models. Overexpression of CPT1A exhibited protective effects in diabetic conditions, improving albuminuria and glomerular sclerosis as well as mitigating glomerular lipid deposits and podocyte injury in streptozotocin-induced diabetic mice. Mechanistically, CPT1A not only fostered lipid consumption via fatty acid metabolism pathways, thereby reducing lipotoxicity, but also anchored Bcl2 to the mitochondrial membrane, thence preventing cytochrome C release and inhibiting the mitochondrial apoptotic process. Furthermore, a novel transcription factor of CPT1A, FOXA1, was identified. We elucidate the crucial role of CPT1A in mitigating podocyte injury and the progression of DKD, indicating that targeting CPT1A may be a promising avenue for DKD treatment. Article Highlights

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisCarnitine O-PalmitoyltransferaseDiabetes Mellitus, ExperimentalDiabetic NephropathiesPodocytesAnimalsHumansMaleMiceAlbuminuriaFatty AcidsHepatocyte Nuclear Factor 1-alphaLipid MetabolismMice, Inbred C57BLProto-Oncogene Proteins c-bcl-2

Substanzen

Carnitine O-PalmitoyltransferaseCPT1A protein, humanFatty AcidsHepatocyte Nuclear Factor 1-alphaProto-Oncogene Proteins c-bcl-2CPT1B protein, mouse

Autor:innen und Institutionen

  • Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

ORCID-Profile: Hua Su, Chun Zhang

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Program of Hubei Province
  • National Key Research and Development Program of China

Zitieren

APA

Xie, Y., Yuan, Q., Tang, B., Xie, Y., Cao, Y., Qiu, Y., Zeng, J., Wang, Z., Su, H., & Zhang, C. (2024). CPT1A Protects Podocytes From Lipotoxicity and Apoptosis In Vitro and Alleviates Diabetic Nephropathy In Vivo. Diabetes. https://doi.org/10.2337/db23-0811

Vancouver

Xie Y, Yuan Q, Tang B, Xie Y, Cao Y, Qiu Y, et al. CPT1A Protects Podocytes From Lipotoxicity and Apoptosis In Vitro and Alleviates Diabetic Nephropathy In Vivo. Diabetes. 2024. doi:10.2337/db23-0811

BibTeX
@article{Xie2024,
  author = {Xie, Yajuan and Yuan, Qian and Tang, Ben and Xie, Yaru and Cao, Yiling and Qiu, Yang and Zeng, Jieyu and Wang, Zhiwen and Su, Hua and Zhang, Chun},
  title = {CPT1A Protects Podocytes From Lipotoxicity and Apoptosis In Vitro and Alleviates Diabetic Nephropathy In Vivo},
  journal = {Diabetes},
  year = {2024},
  doi = {10.2337/db23-0811}
}
Kostenlos starten →